ARCHIVES

FDA Hears More Criticism On Cancer Drug Endpoints; Joint Conferences On Criteria Recommended

This article is from The Cancer Letter archive.

Vol. 15 No. 30 | July 28, 1989

Download PDF Visit The Full Archive

Related Articles

Bush Appoints Andrew von Eschenback, Of M. D. Anderson, As 12th NCI Director.

December 7, 2001

Two OAM Advisors Criticize Third over ACS Membership

July 23, 1993

NCI forms pediatric central IRB.

July 30, 2004

R01 Grants Pool, New Investigators Hit By Budget Strains

October 27, 1989

Four RFAs Released For RM Program

November 6, 1981

NCI Director Broder, Going On 3rd Year, Examines Issues Of Funding, Priorities, For Institute’s Future

September 20, 1991